News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Johnson & Johnson (JNJ) Fails to Win FDA OK for Daily HIV Pill



5/30/2012 7:19:36 AM

Johnson & Johnson said federal drug regulators have not approved its application to market a once-per-day version of its HIV pill Prezista and wants more information. The company said it is reviewing the Food and Drug Administration's response to its marketing application for an 800-milligram Prezista pill, and it plans to respond as quickly as possible. Johnson & Johnson said it does not expect to have to run any new clinical trials of the drug.



comments powered by Disqus
   
HIV/AIDS

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES